Summary

Do you want to shape the future of life science, but need more knowledge about what drives growth and innovation in the field?

Up to 8.6% annual growth and 30,000 additional jobs by the year 2030. These are some of the numbers that make the growth potential in life science very tangible. If you and your company want to play a central role, you must be able to apply new thinking, to take an active part in strategic collaborations, and contribute to breaking down silos internally and across industry and sector boundaries. The future life science industry is based on the integration of data, converging products, services, and strategic partnerships. Furthermore, the requirements for innovation capability are continuously increasing – especially the capability and will to contribute to a more sustainable society and healthcare system.

This four-day Masterclass gives you insights, tools, and competencies that strengthen your own position in a competitive market and at the same time enables you to support the continued growth of your company. During 2x2 course days, you go through 4 modules that provide you with the prerequisites for business innovation in life science.

The Masterclass is offered as a collaboration between CBS Executive Fonden and Atrium and offers engaging training and inspirational key-note presentations from industry thought leaders and practitioners as well as researchers. 

Researchers from Copenhagen Business School (CBS) contribute with the latest theoretical knowledge and cases within leadership, ESG, digitalisation, and innovation, while experienced leaders from life science contribute with concrete insights and experiences from life science and the healthcare system.

There will be plenty of networking opportunities as well as interaction with peers as the Masterclass to a large extent is designed around group-based case work.

Advisory board ensures quality and relevance

The Masterclass in Business Innovation in Life Science was established through collaboration with a strong advisory board consisting of leading experts in the field. By virtue of their knowledge of market needs, they will continue to make recommendations for adjustments. The goal is to ensure that the Masterclass is based on the most important competence needs driving business innovation in the life science industry.

Atrium’s advisory board for business innovation in life science consists of:

• Pernille Schmidt, Director Healthcare Development, Roche Diagnostics
• Diana Arsovic Nielsen, CEO, Danish Life Science Cluster
• Thomas Senderovitz, Senior Vice President Data Science, Novo Nordisk
• Kasim Kutay, CEO, Novo Holdings
• Anne Marie Jess Hansen, CEO, CBS Executive Fonden
• Lars Christian Ohnemus, Director of Center for Corporate Governance (CCG), CBS
• Søren-Ulrik Rolsted Fangholm, Managing Director, DLIMI, and COO, Lif
• Sysser M. A. Ærtebjerg, Managing Director, Atrium
• Lene Gerlach, Partner, Eir Ventures / Chairperson WiLD (Women in Life Science Denmark)

Keywords

• Business and product innovation
• Digital health
• Data Science and AI enabled innovation
• Private-public innovation partnerships
• ESG enabling innovation